“Association of Ruxolitinib Cream Initiation With Continued Reduction in Use of Other Topical Treatments, Oral Corticosteroids, and Biologics for Atopic Dermatitis”. 2024. SKIN The Journal of Cutaneous Medicine 8 (6): s455. https://doi.org/10.25251/skin.8.supp.455.